Occasionally I co-author articles and papers.
| Type | Title | Published in / event | Date | Link |
|---|---|---|---|---|
| Book. | Patient Involvement in Health Technology Assessment. Chapter: Research into Patient Aspects | Springer Nature. Part of the book series: Health Informatics (HI) | 2026 | Read |
| Article | Patient Engagement and Patient Experience Data in Regulatory Review and Health Technology Assessment: Where Are We Today? | Therapeutic Innovation & Regulatory Science (Springer Nature) | April 2025 | Read |
| Article | Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape | International Journal of Technology Assessment in Health Care (Cambridge University Press) | November 2024 | Read |
| Paper | Patient involvement in HTA in Europe: Recommendations from a 360° view of current patient involvement practices | HTAi | October 2023 | Read |
| Article | Building from Patient Experiences to Deliver Patient-Focused Healthcare Systems in Collaboration with Patients: A Call to Action | Therapeutic Innovation & Regulatory Science (Springer Nature) | July 2022 | Read |
| Presentation | Health Technology Assessment: Global alignment of systems, stakeholders and emerging trends | University of Oxford, MSc in Translational Health Sciences (podcast; Neil starts at 0:48) | December 2021 | Listen |
| Paper | Deep Dive – PPI abroad: A patient advocacy perspective. The evolving practice of patient and public involvement in Europe and the United States | Swiss Clinical Trial Organisation, Regulatory Affairs Watch, Issue 6 | October 2021 | Read |
| Report | Best-practice guidance for the health technology assessment of diagnostics and treatments for COVID-19 | Zenodo | September 2021 | Read |
| Article | Valuing patient engagement: reflexive learning in evidence generation practices for health technology assessment | Social Science & Medicine, vol. 280 | July 2021 | Read |
| Article | Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action | Therapeutic Innovation & Regulatory Science (Springer Nature) | May 2021 | Read |
| Article | The Role of Patient Experience in the Value Assessment of Complex Technologies – Do HTA Bodies Need to Reconsider How Value is Assessed? | Health Policy, vol. 125, issue 5 | May 2021 | Read |
| Research paper | Understanding multi-stakeholder needs, preferences and expectations to define effective practices and processes of patient engagement in medicine development: A mixed-methods study | Health Expectations (Wiley) | February 2021 | Read |
| Book chapter | Putting Patients at the Centre of Healthcare: Progress and Challenges for Health Technology Assessments | Springer Nature | July 2018 | Read |
| Book chapter | What do stakeholders expect from patient engagement: Are these expectations being met? | National Library of Medicine | June 2018 | Read |
| Article | Patient Centricity and Pharmaceutical Companies: Is It Feasible? | Therapeutic Innovation & Regulatory Science (Springer Nature) | December 2017 | Read |
| Book chapter | Reflections for Future Development | Springer Nature, Patient Involvement in Health Technology Assessment, pp. 419–427 | May 2017 | Read |
| Book chapter | Moving Center Stage: patients claim their role in healthcare | Farmeconomia – Health economics and therapeutic pathways | March 2016 | Read |
| Book chapter | Strengthening international patient advocacy perspectives on patient involvement in HTA within the HTAi Patient and Citizen Involvement Interest Group | Research Involvement and Engagement (BMC) | January 2016 | Read |
